Brighton Jones LLC’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,900
| Closed | -$28.1K | – | 661 |
|
|
2024
Q1 | $28.1K | Hold |
1,900
| – | – | ﹤0.01% | 620 |
|
|
2023
Q4 | $27.6K | Hold |
1,900
| – | – | ﹤0.01% | 570 |
|
|
2023
Q3 | $20.5K | Hold |
1,900
| – | – | ﹤0.01% | 537 |
|
|
2023
Q2 | $24.5K | Hold |
1,900
| – | – | ﹤0.01% | 541 |
|
|
2023
Q1 | $25.1K | Hold |
1,900
| – | – | ﹤0.01% | 511 |
|
|
2022
Q4 | $28.5K | Hold |
1,900
| – | – | ﹤0.01% | 470 |
|
|
2022
Q3 | $22K | Hold |
1,900
| – | – | ﹤0.01% | 458 |
|
|
2022
Q2 | $21K | Sell |
1,900
-50
| -3% | -$553 | ﹤0.01% | 469 |
|
|
2022
Q1 | $58K | Buy |
1,950
+10
| +0.5% | +$297 | ﹤0.01% | 503 |
|
|
2021
Q4 | $51K | Hold |
1,940
| – | – | ﹤0.01% | 521 |
|
|
2021
Q3 | $70K | Hold |
1,940
| – | – | ﹤0.01% | 474 |
|
|
2021
Q2 | $84K | Hold |
1,940
| – | – | ﹤0.01% | 469 |
|
|
2021
Q1 | $66K | Hold |
1,940
| – | – | ﹤0.01% | 423 |
|
|
2020
Q4 | $68K | Buy |
1,940
+40
| +2% | +$1.4K | ﹤0.01% | 389 |
|
|
2020
Q3 | $46K | Hold |
1,900
| – | – | ﹤0.01% | 328 |
|
|
2020
Q2 | $35K | Hold |
1,900
| – | – | ﹤0.01% | 294 |
|
|
2020
Q1 | $30K | Buy |
1,900
+100
| +6% | +$1.58K | ﹤0.01% | 276 |
|
|
2019
Q4 | $39K | Hold |
1,800
| – | – | ﹤0.01% | 317 |
|
|
2019
Q3 | $34K | Buy |
+1,800
| New | +$34K | ﹤0.01% | 305 |
|